This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Vernagen, LLC. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: David Pak - Innovator in mRNA Vaccine Technology
Introduction
David Pak is a prominent inventor based in Suwanee, GA (US). He has made significant contributions to the field of vaccine development, particularly focusing on respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). His innovative work has the potential to impact public health positively.
Latest Patents
David Pak holds a patent for a respiratory syncytial virus mRNA vaccine. This patent includes a vaccine composition that comprises messenger ribonucleic acid (mRNA) encoding RSV mutant F B strain protein. Additionally, it outlines a method for inducing an immune response against RSV by administering an effective amount of the vaccine composition to a subject in need. Furthermore, his patent also covers a vaccine composition that targets both RSV and hMPV, showcasing his commitment to advancing vaccine technology.
Career Highlights
David Pak is associated with Vernagen, LLC, where he continues to work on groundbreaking vaccine research. His dedication to innovation in the field of immunology is evident through his patent and ongoing research efforts.
Collaborations
David collaborates with talented individuals such as Jack Yoon and Baek Kim. Their combined expertise contributes to the advancement of vaccine development and research.
Conclusion
David Pak is a key figure in the development of mRNA vaccines, particularly for RSV and hMPV. His innovative work and collaborations are paving the way for future advancements in vaccine technology.